Research suggests that zinc-L-carnosine may offer supportive benefits in the context of Helicobacter pylori eradication therapy, primarily through its known gastrointestinal mucosal protective properties. A 2023 narrative review examining carnosine-related compounds across multiple areas of human medicine found supportive evidence for zinc-L-carnosine's role in H. pylori eradication protocols, though the review synthesized findings broadly rather than focusing on controlled trials specific to this indication alone. While the direction of available evidence is generally favorable, the current body of research remains limited in scope, and more rigorous study designs such as large-scale randomized controlled trials focused specifically on zinc-L-carnosine's contribution to H. pylori outcomes would strengthen the evidence base considerably.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Revie... | Review | 2023 | Supports | 100 |